

Wondering why Ethyl Chloride is so hard to find in 2026? Learn why this topical anesthetic spray faces supply issues and what you can do about it.
Ethyl Chloride — sold as Gebauer's Ethyl Chloride — is a topical anesthetic spray used by doctors, nurses, and other healthcare professionals to temporarily numb the skin before injections, IV starts, and minor surgical procedures. It's also widely used in sports medicine and physical therapy for treating muscle pain.
But in recent years, many healthcare providers and patients have noticed that Ethyl Chloride can be surprisingly difficult to get. If you've been told your provider is out of stock or that the product is on backorder, here's what's going on — and what you can do about it.
Ethyl Chloride (also known as Chloroethane) is a vapocoolant — a spray that rapidly cools the skin when applied. This cooling effect temporarily numbs the area for about 60 seconds, making it useful for controlling pain during needle procedures, minor surgeries, and sports injuries.
It's classified by the FDA as a prescription medical device, not a traditional drug. That distinction matters because it affects how it's manufactured, distributed, and regulated.
Common uses for Ethyl Chloride include:
For a deeper dive into what this product does, check out our guide on What Is Ethyl Chloride: Uses, Dosage, and What You Need to Know.
There are several reasons why Ethyl Chloride can be difficult to find in 2026. Here are the main factors driving supply challenges:
Gebauer Company in Cleveland, Ohio is essentially the sole manufacturer of medical-grade Ethyl Chloride in the United States. When you have only one company making a product, any disruption to their production — whether it's a raw material shortage, equipment maintenance, or a regulatory issue — can affect the entire supply chain. There is no generic alternative to fall back on.
Ethyl Chloride (Chloroethane) is a highly flammable chemical that requires careful handling, storage, and shipping. The raw material must meet strict quality standards for medical use, and not all chemical suppliers can provide the grade needed. Supply chain disruptions affecting chemical manufacturing have made sourcing these materials more challenging in recent years.
Because Ethyl Chloride is classified as an FDA-cleared medical device rather than a pharmaceutical drug, it doesn't go through the same supply chain as most medications. This means it may not be stocked by every pharmacy or distributor, and healthcare facilities may need to order through specialized medical supply channels like McKesson or McGuff Medical.
As more healthcare facilities focus on patient comfort — particularly in pediatric settings and emergency departments — demand for vapocoolant sprays has grown. This increased demand, combined with limited manufacturing capacity from a single source, can lead to periodic stockouts.
If your provider or facility is having trouble getting Ethyl Chloride, here are some practical steps:
For more detailed tips on tracking down this product, read our guide on How to Find Ethyl Chloride in Stock Near You.
Ethyl Chloride is a valuable tool for pain management in clinical settings, but its single-source manufacturing, specialized handling requirements, and growing demand make it vulnerable to supply disruptions. The good news is that alternatives exist, and tools like Medfinder can help you track down availability in real time.
If you're a healthcare provider dealing with supply challenges, check out our provider-focused guide on what prescribers need to know about the Ethyl Chloride shortage in 2026.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.